114 related articles for article (PubMed ID: 30721053)
1. Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT
Sniecikowska J; Gluch-Lutwin M; Bucki A; Więckowska A; Siwek A; Jastrzebska-Wiesek M; Partyka A; Wilczyńska D; Pytka K; Pociecha K; Cios A; Wyska E; Wesołowska A; Pawłowski M; Varney MA; Newman-Tancredi A; Kolaczkowski M
J Med Chem; 2019 Mar; 62(5):2750-2771. PubMed ID: 30721053
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT
Sniecikowska J; Gluch-Lutwin M; Bucki A; Więckowska A; Siwek A; Jastrzebska-Wiesek M; Partyka A; Wilczyńska D; Pytka K; Latacz G; Przejczowska-Pomierny K; Wyska E; Wesołowska A; Pawłowski M; Newman-Tancredi A; Kolaczkowski M
J Med Chem; 2020 Oct; 63(19):10946-10971. PubMed ID: 32883072
[TBL] [Abstract][Full Text] [Related]
3. From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery.
Sniecikowska J; Newman-Tancredi A; Kolaczkowski M
Curr Top Med Chem; 2019; 19(26):2393-2420. PubMed ID: 31544717
[TBL] [Abstract][Full Text] [Related]
4. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
5. Activity of Serotonin 5-HT
Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
[TBL] [Abstract][Full Text] [Related]
6. NLX-101, a highly selective 5-HT
Depoortère R; Auclair AL; Newman-Tancredi A
Behav Brain Res; 2021 Mar; 401():113082. PubMed ID: 33358917
[TBL] [Abstract][Full Text] [Related]
7. Translating biased agonists from molecules to medications: Serotonin 5-HT
Newman-Tancredi A; Depoortère RY; Kleven MS; Kołaczkowski M; Zimmer L
Pharmacol Ther; 2022 Jan; 229():107937. PubMed ID: 34174274
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
[TBL] [Abstract][Full Text] [Related]
9. Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT
Newman-Tancredi A; Martel JC; Cosi C; Heusler P; Lestienne F; Varney MA; Cussac D
J Pharm Pharmacol; 2017 Sep; 69(9):1178-1190. PubMed ID: 28612503
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT
Yuan RX; Jiang KY; Wu JW; Zhang ZX; Li MS; Li JQ; Ni F
Bioorg Med Chem Lett; 2022 Nov; 76():129006. PubMed ID: 36202190
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT
Głuch-Lutwin M; Sałaciak K; Pytka K; Gawalska A; Jamrozik M; Śniecikowska J; Kołaczkowski M; Depoortère RY; Newman-Tancredi A
Behav Brain Res; 2023 Feb; 438():114207. PubMed ID: 36368443
[TBL] [Abstract][Full Text] [Related]
12. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
13. Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.
Bruins Slot LA; De Vries L; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2006 Mar; 534(1-3):63-70. PubMed ID: 16497294
[TBL] [Abstract][Full Text] [Related]
14. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological MRI to investigate the functional selectivity of 5-HT
Vidal B; Bolbos R; Redouté J; Langlois JB; Costes N; Newman-Tancredi A; Zimmer L
Neuropharmacology; 2020 Aug; 172():107867. PubMed ID: 31783063
[TBL] [Abstract][Full Text] [Related]
17. Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
Peglion JL; Goument B; Despaux N; Charlot V; Giraud H; Nisole C; Newman-Tancredi A; Dekeyne A; Bertrand M; Genissel P; Millan MJ
J Med Chem; 2002 Jan; 45(1):165-76. PubMed ID: 11754589
[TBL] [Abstract][Full Text] [Related]
18. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.
Berrocoso E; Mico JA
Int J Neuropsychopharmacol; 2009 Feb; 12(1):61-71. PubMed ID: 18405417
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling.
Sałaciak K; Głuch-Lutwin M; Siwek A; Szafarz M; Kazek G; Bednarski M; Nowiński L; Mitchell E; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Kołaczkowski M; Szkaradek N; Marona H; Sapa J; Pytka K
J Psychopharmacol; 2020 Dec; 34(12):1431-1442. PubMed ID: 33103555
[TBL] [Abstract][Full Text] [Related]
20. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
Maeda K; Sugino H; Akazawa H; Amada N; Shimada J; Futamura T; Yamashita H; Ito N; McQuade RD; Mørk A; Pehrson AL; Hentzer M; Nielsen V; Bundgaard C; Arnt J; Stensbøl TB; Kikuchi T
J Pharmacol Exp Ther; 2014 Sep; 350(3):589-604. PubMed ID: 24947465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
